ASpirin for Patients With SEPsis and SeptIc Shock

NCT01784159 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

167

Enrollment

OTHER

Sponsor class

Stopped Terminated: The study was stopped prematurely and will not be resumed due to the higher number of bleeding cases in the intervention group, as recomended by the Data Safety Monitoring Board on February 7, 2023.

Conditions

Sepsis

Interventions

DRUG: Aspirin

Sponsor

Federal University of São Paulo